| Literature DB >> 31007865 |
Qingqing Xiong1,2, Gha Young Lee1, Jianxun Ding1, Wenliang Li1,3, Jinjun Shi1.
Abstract
As an attractive alternative to plasmid DNA, messenger RNA (mRNA) has recently emerged as a promising class of nucleic acid therapeutics for biomedical applications. Advances in addressing the inherent shortcomings of mRNA and in the development of nanoparticle-based delivery systems have prompted the development and clinical translation of mRNA-based medicines. In this review, we discuss the chemical modification strategies of mRNA to improve its stability, minimize immune responses, and enhance translational efficacy. We also highlight recent progress in nanoparticle-based mRNA delivery. Considerable attention is given to the increasingly widespread applications of mRNA nanomedicine in the biomedical fields of vaccination, protein-replacement therapy, gene editing, and cellular reprogramming and engineering.Entities:
Keywords: cellular reprogramming; chemical modification; engineering; gene editing; messenger RNA; nanoparticle; protein-replacement; vaccination
Year: 2018 PMID: 31007865 PMCID: PMC6472920 DOI: 10.1007/s12274-018-2146-1
Source DB: PubMed Journal: Nano Res ISSN: 1998-0000 Impact factor: 8.897